Cargando…

Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management

Aspirin is one of the most widely used medications across the global healthcare system and is the foundation in treating ischemic heart disease, as well as secondary prevention for ischemic and valvular heart disease. Challenges arise in treating patients with cardiovascular disease who have concomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakker, Ravi A., Salazar, Leonardo, Jazar, Deaa Abu, Bhakta, Pooja, Baker, Bryan, Patel, Chandani, Elbadawi, Ayman, Agarwal, Mayank, Albaeni, Aiham, Saleh, Mohammed, Esclovan, Jonathan, El Haddad, Danielle, Alwash, Hashim, Kalra, Ankur, Goel, Sachin S., Widmer, Robert Jay, Chatila, Khaled, Khalife, Wissam, Motiwala, Afaq, McCracken, Jennifer, Jneid, Hani, Gilani, Syed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135937/
https://www.ncbi.nlm.nih.gov/pubmed/35344187
http://dx.doi.org/10.1007/s40119-022-00255-9
_version_ 1784714067997360128
author Thakker, Ravi A.
Salazar, Leonardo
Jazar, Deaa Abu
Bhakta, Pooja
Baker, Bryan
Patel, Chandani
Elbadawi, Ayman
Agarwal, Mayank
Albaeni, Aiham
Saleh, Mohammed
Esclovan, Jonathan
El Haddad, Danielle
Alwash, Hashim
Kalra, Ankur
Goel, Sachin S.
Widmer, Robert Jay
Chatila, Khaled
Khalife, Wissam
Motiwala, Afaq
McCracken, Jennifer
Jneid, Hani
Gilani, Syed
author_facet Thakker, Ravi A.
Salazar, Leonardo
Jazar, Deaa Abu
Bhakta, Pooja
Baker, Bryan
Patel, Chandani
Elbadawi, Ayman
Agarwal, Mayank
Albaeni, Aiham
Saleh, Mohammed
Esclovan, Jonathan
El Haddad, Danielle
Alwash, Hashim
Kalra, Ankur
Goel, Sachin S.
Widmer, Robert Jay
Chatila, Khaled
Khalife, Wissam
Motiwala, Afaq
McCracken, Jennifer
Jneid, Hani
Gilani, Syed
author_sort Thakker, Ravi A.
collection PubMed
description Aspirin is one of the most widely used medications across the global healthcare system and is the foundation in treating ischemic heart disease, as well as secondary prevention for ischemic and valvular heart disease. Challenges arise in treating patients with cardiovascular disease who have concomitant aspirin intolerance. Through an extensive review of the literature, we provide a comprehensive background on the pharmacology of aspirin, the mechanisms behind aspirin intolerance, the importance of aspirin in cardiovascular disease, and the management of aspirin intolerance in both acute coronary syndrome and stable coronary artery disease. Our review includes a multidisciplinary approach from the internist, allergist/immunologist, and cardiologist when evaluating this important patient population.
format Online
Article
Text
id pubmed-9135937
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-91359372022-05-28 Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management Thakker, Ravi A. Salazar, Leonardo Jazar, Deaa Abu Bhakta, Pooja Baker, Bryan Patel, Chandani Elbadawi, Ayman Agarwal, Mayank Albaeni, Aiham Saleh, Mohammed Esclovan, Jonathan El Haddad, Danielle Alwash, Hashim Kalra, Ankur Goel, Sachin S. Widmer, Robert Jay Chatila, Khaled Khalife, Wissam Motiwala, Afaq McCracken, Jennifer Jneid, Hani Gilani, Syed Cardiol Ther Review Aspirin is one of the most widely used medications across the global healthcare system and is the foundation in treating ischemic heart disease, as well as secondary prevention for ischemic and valvular heart disease. Challenges arise in treating patients with cardiovascular disease who have concomitant aspirin intolerance. Through an extensive review of the literature, we provide a comprehensive background on the pharmacology of aspirin, the mechanisms behind aspirin intolerance, the importance of aspirin in cardiovascular disease, and the management of aspirin intolerance in both acute coronary syndrome and stable coronary artery disease. Our review includes a multidisciplinary approach from the internist, allergist/immunologist, and cardiologist when evaluating this important patient population. Springer Healthcare 2022-03-28 2022-06 /pmc/articles/PMC9135937/ /pubmed/35344187 http://dx.doi.org/10.1007/s40119-022-00255-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review
Thakker, Ravi A.
Salazar, Leonardo
Jazar, Deaa Abu
Bhakta, Pooja
Baker, Bryan
Patel, Chandani
Elbadawi, Ayman
Agarwal, Mayank
Albaeni, Aiham
Saleh, Mohammed
Esclovan, Jonathan
El Haddad, Danielle
Alwash, Hashim
Kalra, Ankur
Goel, Sachin S.
Widmer, Robert Jay
Chatila, Khaled
Khalife, Wissam
Motiwala, Afaq
McCracken, Jennifer
Jneid, Hani
Gilani, Syed
Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management
title Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management
title_full Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management
title_fullStr Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management
title_full_unstemmed Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management
title_short Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management
title_sort coronary artery disease and aspirin intolerance: background and insights on current management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135937/
https://www.ncbi.nlm.nih.gov/pubmed/35344187
http://dx.doi.org/10.1007/s40119-022-00255-9
work_keys_str_mv AT thakkerravia coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT salazarleonardo coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT jazardeaaabu coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT bhaktapooja coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT bakerbryan coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT patelchandani coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT elbadawiayman coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT agarwalmayank coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT albaeniaiham coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT salehmohammed coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT esclovanjonathan coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT elhaddaddanielle coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT alwashhashim coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT kalraankur coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT goelsachins coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT widmerrobertjay coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT chatilakhaled coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT khalifewissam coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT motiwalaafaq coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT mccrackenjennifer coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT jneidhani coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement
AT gilanisyed coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement